Fulgent Genetics registers $50 million stock for initial public sale

Credit Suisse, Cowen, Piper Jaffray, Raymond James, BTIG will assist

By Devika Patel

Knoxville, Tenn., Sept. 2 – Fulgent Genetics, Inc. will price its initial public sale of common stock with a 30-day greenshoe, according to a form S-1 filed Friday with the Securities and Exchange Commission. The company has registered up to $50 million of stock.

Credit Suisse Securities (USA) LLC and Piper Jaffray & Co. are the bookrunners. Raymond James & Associates is the lead manager, and BTIG is the co-manager.

Proceeds will be used for working capital and general corporate purposes.

The technology company is based in Temple City, Calif. The company intends to list its common stock on the Nasdaq stock exchange under the symbol “FLGT.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.